Susquehanna International Group’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-46,200
| Closed | -$899K | – | 10965 |
|
|
2018
Q1 | $899K | Buy |
46,200
+29,000
| +169% | +$569K | ﹤0.01% | 5479 |
|
|
2017
Q4 | $286K | Sell |
17,200
-57,700
| -77% | -$1.06M | ﹤0.01% | 7669 |
|
|
2017
Q3 | $1.52M | Sell |
74,900
-15,800
| -17% | -$302K | ﹤0.01% | 4433 |
|
|
2017
Q2 | $1.46M | Buy |
+90,700
| New | +$1.34M | ﹤0.01% | 4490 |
|
|
2016
Q3 | – | Sell |
-43,300
| Closed | -$1.25M | – | 9436 |
|
|
2016
Q2 | $1.25M | Buy |
43,300
+26,700
| +161% | +$870K | ﹤0.01% | 4406 |
|
|
2016
Q1 | $532K | Buy |
16,600
+6,800
| +69% | +$239K | ﹤0.01% | 6293 |
|
|
2015
Q4 | $419K | Buy |
+9,800
| New | +$391K | ﹤0.01% | 7106 |
|
|
2015
Q3 | – | Sell |
-7,500
| Closed | -$344K | – | 10603 |
|
|
2015
Q2 | $344K | Buy |
+7,500
| New | +$356K | ﹤0.01% | 8308 |
|
|
2015
Q1 | – | Sell |
-29,600
| Closed | -$938K | – | 10279 |
|
|
2014
Q4 | $938K | Buy |
29,600
+18,200
| +160% | +$533K | ﹤0.01% | 6001 |
|
|
2014
Q3 | $270K | Sell |
11,400
-75,100
| -87% | -$1.92M | ﹤0.01% | 8189 |
|
|
2014
Q2 | $2.59M | Sell |
86,500
-6,500
| -7% | -$175K | ﹤0.01% | 4167 |
|
|
2014
Q1 | $2.46M | Buy |
93,000
+77,500
| +500% | +$1.94M | ﹤0.01% | 3979 |
|
|
2013
Q4 | $390K | Sell |
15,500
-58,400
| -79% | -$1.3M | ﹤0.01% | 7148 |
|
|
2013
Q3 | $1.52M | Sell |
73,900
-8,300
| -10% | -$171K | ﹤0.01% | 4580 |
|
|
2013
Q2 | $1.64M | Buy |
+82,200
| New | +$1.46M | ﹤0.01% | 4213 |
|
Susquehanna International Group's IPXL Position: Q1 2018 in Review
Susquehanna International Group sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 27,834 shares — an estimated $546K sold.
Susquehanna International Group first reported a position in IPXL in Q2 2013 and held it in 15 quarters. The position peaked at $5.04M in Q1 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.
- Susquehanna International Group reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
- Susquehanna International Group sold 27,834 Impax Laboratories, Inc. shares in Q1 2018, an estimated $546K.
- Susquehanna International Group first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 15 quarters.
- Susquehanna International Group's Impax Laboratories, Inc. position peaked at $5.04M in Q1 2015.
- 188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.
Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.